Timber Pharmaceuticals
(AMEX:TMBR)
Timber Pharmaceuticals, Inc. Common Stock recently split on Wednesday, November 9, 2022 with a ratio of 1:50
$1.4007
0.0707[5.32%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$1.50
0.0993[7.09%]
After Hours: 6:40PM EDT
Day Range1.33 - 1.5352 Wk Range1.32 - 24.95Open / Close1.37 / 1.45Float / Outstanding2.9M / 2.9M
Vol / Avg.266.8K / 165.3KMkt Cap4.1MP/E-50d Avg. Price3.46
Div / Yield-Payout Ratio-Total Float2.9MEPS-1.52

Timber Pharmaceuticals Stock (AMEX:TMBR), Quotes and News Summary

Timber Pharmaceuticals Stock (AMEX: TMBR) stock price, news, charts, stock research, profile.

Loading...
Day Range1.33 - 1.5352 Wk Range1.32 - 24.95Open / Close1.37 / 1.45Float / Outstanding2.9M / 2.9M
Vol / Avg.266.8K / 165.3KMkt Cap4.1MP/E-50d Avg. Price3.46
Div / Yield-Payout Ratio-Total Float2.9MEPS-1.52
Seeking Alpha - Nov 14, 2022, 8:50AM
StockNews - Sep 23, 2022, 8:36AM
StockNews - Aug 23, 2022, 9:11AM
InvestorsObserver - May 3, 2022, 10:44AM
Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and scleroderma. The company's development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist).

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-1.520
REV0
Q2 2022Est.ActualSurprise
EPS-7.500
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Timber Pharmaceuticals (TMBR) stock?

A

You can purchase shares of Timber Pharmaceuticals (AMEX: TMBR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Timber Pharmaceuticals's (TMBR) competitors?

A

There are no as such competitors for Timber Pharmaceuticals.

Q

What is the target price for Timber Pharmaceuticals (TMBR) stock?

A

The latest price target for Timber Pharmaceuticals (AMEX: TMBR) was reported by HC Wainwright & Co. on Wednesday, October 26, 2022. The analyst firm set a price target for 1.00 expecting TMBR to fall to within 12 months (a possible -28.61% downside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Timber Pharmaceuticals (TMBR)?

A

The stock price for Timber Pharmaceuticals (AMEX: TMBR) is $1.4007 last updated November 30, 2022, 8:59 PM UTC.

Q

Does Timber Pharmaceuticals (TMBR) pay a dividend?

A

There are no upcoming dividends for Timber Pharmaceuticals.

Q

When is Timber Pharmaceuticals (AMEX:TMBR) reporting earnings?

A

Timber Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 14, 2022.

Q

Is Timber Pharmaceuticals (TMBR) going to split?

A

There is no upcoming split for Timber Pharmaceuticals.

Q

What sector and industry does Timber Pharmaceuticals (TMBR) operate in?

A

Timber Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.